Narrow search
Showing 1 - 10 of 7,826
Cover Image
National Regulation and International Industry Structure in Pharmaceuticals
Roevekamp, Frank - 2011
industry activities proceeds, national regulation aimed at reducing costs for pharmaceuticals can have the unintended effect of …This paper looks into various means of regulating pharmaceuticals and their effects on the structure of the … international pharmaceutical industry. Regulation adds complexity to the activities of a firm. This complexity is multiplied, if …
Persistent link: https://www.econbiz.de/10013127115
Cover Image
Chapter Twelve. Markets for Pharmaceutical Products
Scott Morton, Fiona; Kyle, Margaret - In: Handbook of health economics : volume 2, (pp. 763-823). 2011
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is … also characterized by extensive regulation of almost every activity, from product development through manufacturing and …
Persistent link: https://www.econbiz.de/10014025576
Cover Image
Is medicines parallel trade "regulatory arbitrage"?
Costa-Font, Joan - 2015
regulation, and not by price differences in line with the hypothesis of "regulatory arbitrage". …
Persistent link: https://www.econbiz.de/10010477153
Cover Image
Pharmaceutical regulation at the wholesale level and parallel trade
Birg, Laura - 2013
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by …
Persistent link: https://www.econbiz.de/10010223101
Cover Image
Regulation of pharmaceutical prices : evidence from a reference price reform in Denmark ; conference paper
Kaiser, Ulrich; Méndez, Susan; Rønde, Thomas; … - 2013 - This version: February 23, 2013
Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an "external" (based on a basket of prices in other countries) to an "internal" (based on comparable domestic products) reference price system. We find...
Persistent link: https://www.econbiz.de/10010339324
Cover Image
How do drug prices respond to a change from external to internal reference pricing? : evidence from a Danish regulatory reform
Kaiser, Ulrich; Méndez, Susan J. - 2015
We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals …
Persistent link: https://www.econbiz.de/10010467805
Cover Image
How do drug prices respond to a change from external to internal reference pricing? : evidence from a Danish regulatory reform
Kaiser, Ulrich; Mendez, Susan J. - 2015 - This version: January 5, 2015
We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals …
Persistent link: https://www.econbiz.de/10010462523
Cover Image
Consequences of disclosing clinical trial results : evidence from the food and drug administration amendments act
Bourveau, Thomas; Capkun, Vedran; Wang, Yin - 2020
We examine how the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires additional disclosures regarding clinical trial results, impacts information asymmetry between the disclosing pharmaceutical firm and capital market participants, the general public, academics,...
Persistent link: https://www.econbiz.de/10012295656
Cover Image
Drug quality and safety issues in India
Chokshi, Maulik; Mongia, Rahul; Wattal, Vasudha - 2015
developing world, it is believed that there is need for strict quality specification and enforcement within the country in the …
Persistent link: https://www.econbiz.de/10011337690
Cover Image
Pharmaceutical regulation and health policy objectives
Birg, Laura - 2013
public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …
Persistent link: https://www.econbiz.de/10010224844